Literature DB >> 20353301

Contribution of oxygen-limiting conditions to persistent infection of Pseudomonas aeruginosa.

Max Schobert1, Petra Tielen.   

Abstract

Pseudomonas aeruginosa is a versatile opportunistic human pathogen that is able to colonize a broad spectrum of different aquatic and soil habitats. In the environment and during pathogenesis, P. aeruginosa encounters oxygen-limited and anaerobic environments. Particularly during chronic infection of the cystic fibrosis lung, oxygen-limiting conditions seem to contribute to persistent infection. Oxygen limitation increases antibiotic tolerance, robust biofilms and alginate biosynthesis, which contribute to the persistence of this opportunistic pathogen. Despite the importance of anaerobic metabolism during persistent infection of P. aeruginosa, we are just beginning to understand the underlying regulatory network and the molecular basis of how anaerobic metabolism contributes to a persistent infection. A deeper understanding of the anaerobic physiology of P. aeruginosa will allow the identification of new antibiotic targets and new therapeutic strategies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20353301     DOI: 10.2217/fmb.10.16

Source DB:  PubMed          Journal:  Future Microbiol        ISSN: 1746-0913            Impact factor:   3.165


  29 in total

1.  Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.

Authors:  Sherie Smith; Valerie Waters; Nikki Jahnke; Felix Ratjen
Journal:  Cochrane Database Syst Rev       Date:  2020-06-10

Review 2.  Regulation of bacterial virulence gene expression by cell envelope stress responses.

Authors:  Josué Flores-Kim; Andrew J Darwin
Journal:  Virulence       Date:  2014       Impact factor: 5.882

3.  Chlorinated phenols control the expression of the multidrug resistance efflux pump MexAB-OprM in Pseudomonas aeruginosa by interacting with NalC.

Authors:  Sudeshna Ghosh; Claudia M Cremers; Ursula Jakob; Nancy G Love
Journal:  Mol Microbiol       Date:  2011-02-15       Impact factor: 3.501

4.  Enzymatic characterization and in vivo function of five terminal oxidases in Pseudomonas aeruginosa.

Authors:  Hiroyuki Arai; Takuro Kawakami; Tatsuya Osamura; Takehiro Hirai; Yoshiaki Sakai; Masaharu Ishii
Journal:  J Bacteriol       Date:  2014-09-02       Impact factor: 3.490

Review 5.  Targeting bacterial membrane function: an underexploited mechanism for treating persistent infections.

Authors:  Julian G Hurdle; Alex J O'Neill; Ian Chopra; Richard E Lee
Journal:  Nat Rev Microbiol       Date:  2011-01       Impact factor: 60.633

6.  Burkholderia cenocepacia phenotypic clonal variation during a 3.5-year colonization in the lungs of a cystic fibrosis patient.

Authors:  Carla P Coutinho; Carla C C R de Carvalho; Andreia Madeira; Ana Pinto-de-Oliveira; Isabel Sá-Correia
Journal:  Infect Immun       Date:  2011-05-02       Impact factor: 3.441

7.  Diffusive transport through a model host-biofilm system.

Authors:  A C Aristotelous; I Klapper; Y Grabovsky; B Pabst; B Pitts; P S Stewart
Journal:  Phys Rev E Stat Nonlin Soft Matter Phys       Date:  2015-08-10

8.  Non-invasive imaging of oxygen concentration in a complex in vitro biofilm infection model using 19 F MRI: Persistence of an oxygen sink despite prolonged antibiotic therapy.

Authors:  Jeffrey W Simkins; Philip S Stewart; Sarah L Codd; Joseph D Seymour
Journal:  Magn Reson Med       Date:  2019-08-02       Impact factor: 4.668

9.  Copper efflux is induced during anaerobic amino acid limitation in Escherichia coli to protect iron-sulfur cluster enzymes and biogenesis.

Authors:  Danny Ka Chun Fung; Wai Yin Lau; Wing Tat Chan; Aixin Yan
Journal:  J Bacteriol       Date:  2013-07-26       Impact factor: 3.490

Review 10.  Mimicking the host and its microenvironment in vitro for studying mucosal infections by Pseudomonas aeruginosa.

Authors:  Aurélie Crabbé; Maria A Ledesma; Cheryl A Nickerson
Journal:  Pathog Dis       Date:  2014-05-23       Impact factor: 3.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.